India to Myanmar: Bromhexine Export Trade Route

The India to Myanmar Bromhexine corridor is one of India's established pharmaceutical export routes, with 113 shipments documented worth a combined $1.3M USD. The route is dominated by EMCURE PHARMACEUTICALS LIMITED, which alone accounts for roughly 79% of all export value, reflecting the consolidated nature of India's bromhexine manufacturing sector.

Across 20 active suppliers, the average shipment value stands at $11.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with bromhexine's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 17.3%, placing it at rank #8 among India's top bromhexine export destinations globally.

On the import side, key buyers of Indian bromhexine in Myanmar include KHETAN COMPANY LIMITED, KETAN COMPANY LIMITED, NI NI MYO MYO COMPANY LIMITED and 20 others. KHETAN COMPANY LIMITED is the single largest importer with 22 shipments valued at $917.5K USD.

India's bromhexine exports to Myanmar are driven primarily by a handful of large-scale manufacturers. EMCURE PHARMACEUTICALS LIMITED with 24 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 20 active exporters signals a competitive but concentrated market — buyers in Myanmar benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — EMCURE PHARMACEUTICALS LIMITED, NEOTEK PHARMACEUTICALS LLP , IPCA LABORATORIES LIMITED — together account for 87% of total trade value on this route. The average shipment value of $11.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceuticals products finished product vifex syrup 100 ml bt salbutamolsulphate bromhexine hydrochloride gu and pharmaceuticals products finished product vifex syrup 100 ml bt salbutamol sulphate bromhexine hydrochloride g, suggesting that buyers in Myanmar tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, KHETAN COMPANY LIMITED is the largest importer with 22 shipments worth $917.5K USD — representing 70% of all bromhexine imports from India on this route. A total of 23 buyers are active on this corridor.